Topic archive

psyence biomed

9 stories

10/21/2026

Psyence BioMed finalizes $2.6M investment in PsyLabs

Psyence BioMed invests in PsyLabs following milestone achievements.

10/21/2026

Investment completion coincides with key ibogaine research milestones.

10/5/2026

Psyence BioMed collaborates with Benuvia to advance ibogaine manufacturing in the US.

10/5/2026

Psyence BioMed partners with Benuvia for U.S. ibogaine production, aiming to advance clinical research.

10/2/2026

Psyence BioMed expands its reach in the US with ibogaine licensing deal.

9/28/2026

Psyence BioMed and PsyLabs collaborate on ibogaine licensing agreement.

9/23/2026

The company aims to advance ibogaine research for mental health.

9/23/2026

Psyence BioMed's new investment aims to advance ibogaine research.

8/19/2026

Former President Trump supports ibogaine research, sparking industry response.